Investment Rating - The report maintains a "Hold" rating for the company with a target price of $255.00, indicating a potential upside of 9.50% from the current stock price of $232.87 [2][4][17]. Core Insights - The company reported total revenue of $94.9 billion for the quarter, a year-over-year increase of 6.1%, surpassing Bloomberg's consensus estimate of $94.4 billion. Product revenue was $70 billion, up 4.1%, while service revenue reached $25 billion, growing 11.9% [15][21]. - The gross profit was $43.9 billion, with a gross margin of 46.2%, exceeding the expected 46.0%. However, net profit fell to $14.7 billion, a decline of 35.8% year-over-year due to a one-time tax payment of $10.2 billion [15][22]. - The report highlights the launch of the iPhone 16, which features upgraded memory and processing capabilities, and anticipates that AI developments will drive future growth in both hardware and software revenues [16][38]. Financial Summary - The company’s net profit projections for FY2024 to FY2027 are as follows: $93.7 billion, $110.9 billion, $119.3 billion, and $126.5 billion respectively, with diluted earnings per share (EPS) expected to grow from $6.1 to $8.9 over the same period [12][17]. - Total operating revenue forecasts for the next few years are $391.0 billion for FY2024, $415.6 billion for FY2025, $442.3 billion for FY2026, and $464.0 billion for FY2027, reflecting a compound annual growth rate (CAGR) of 5.9% [13][49]. - The report indicates that the company’s cash and cash equivalents stood at $15.7 billion, with a net cash position of $5 billion, and it returned over $29 billion to shareholders through stock buybacks and dividends [22][37]. Product Performance - iPhone revenue for the quarter was $46.2 billion, showing a 6% year-over-year increase, with an average selling price (ASP) of $825, up $8 from the previous year [32][36]. - Service revenue reached $25 billion, marking a 12% increase, with over 1 billion paid subscribers across various services [37][40]. - The iPad and Mac segments showed growth, with iPad revenue at $7 billion (up 8%) and Mac revenue at $7.7 billion (up 2%), while wearables and accessories saw a decline of 3% to $9 billion [42][44]. Market Outlook - The report anticipates that the overall revenue growth for FY25Q1 will be in the low to mid-single digits, with gross margins expected to remain between 46% and 47% [15][26]. - The company is expected to benefit from a growing user base in India, with projected hardware sales exceeding $20 billion in the coming years [25].

Investment Rating - The report assigns a "Buy" rating for the company with a target price of $56.29, indicating a potential upside of 32.9% from the current share price of $42.58 [1][3]. Core Insights - The company has shown significant revenue growth, with CARVYKTI revenue increasing by 88% year-over-year to $286 million in Q3 2024, and a total revenue of $160 million for the quarter, representing a 67% increase [1]. - CARVYKTI is the only therapy clinically proven to significantly extend overall survival in multiple myeloma (MM) patients compared to standard therapies, with a median overall survival (mOS) not reached versus 37.75 months, reducing the risk of death by 45% [1]. - The company has a strong cash position of $1.2 billion, which is expected to support operations until 2026, with plans to reach an annual production target of 10,000 doses by the end of 2025 [1]. Financial Summary - The company reported a revenue of $117 million for 2023, with projections of $285 million for 2024 and $632 million for 2025, reflecting a growth rate of 143.7% and 119.1% respectively [2][4]. - Gross margin is expected to improve, with projections of 59% in 2024 and 54% in 2025 [4]. - The company is projected to achieve a net profit of $62 million by 2026, with a significant reduction in losses expected in the coming years [4].

Investment Rating - Buy rating with a target price of HKD 23.12, representing a 33.5% upside from the current price [2] Core Views - The company maintained high single-quarter net profit despite a decline in oil prices, driven by production growth and excellent cost control [2] - The company achieved a net profit of RMB 116.659 billion in the first three quarters, a year-on-year increase of 19.5% [2] - The company's oil and gas production reached 542.1 million barrels of oil equivalent in the first three quarters, with a year-on-year increase of 7.0% [2] - The company's cost per barrel of oil decreased to USD 28.14, with operating costs at USD 7.21 per barrel, placing it among the global leaders in cost control [2] - The company's capital expenditure in the first three quarters was approximately RMB 95.34 billion, a year-on-year increase of 6.6%, with high growth potential in future projects [2] Financial Performance - The company's revenue for Q3 2024 was RMB 99.254 billion, a year-on-year decrease of 13.5% but a sequential increase of 6.3% [2] - The company's net profit for Q3 2024 was RMB 36.928 billion, with a total revenue of RMB 326.024 billion for the first three quarters, a year-on-year increase of 6.3% [2] - The company's oil and gas sales contributed significantly to revenue, with domestic fields like Bozhong and Enping showing strong production growth [2] - The company's realized oil sales price increased from USD 76.8 per barrel in the first three quarters of 2023 to USD 79.0 per barrel in the same period of 2024, narrowing the discount to international oil prices [2] Production and Reserves - The company's net production in Q3 2024 was 179.6 million barrels of oil equivalent, a year-on-year increase of 7.0% [2] - Overseas production growth was driven by the successful commissioning of the Payara project in Guyana [2] - The company secured 9 new offshore exploration blocks and discovered 4 new oil and gas structures, with projects expected to come online between 2024 and 2027 [2] Financial Forecasts - The company is expected to achieve revenues of RMB 451.4 billion, RMB 465.5 billion, and RMB 476.0 billion in 2024, 2025, and 2026, respectively [2] - Net profit is forecasted to be RMB 145.2 billion, RMB 148.9 billion, and RMB 153.0 billion for 2024, 2025, and 2026, respectively [2] - The company's EPS is expected to be RMB 3.05, RMB 3.13, and RMB 3.22 for 2024, 2025, and 2026, respectively [2] Valuation Metrics - The company's PE ratio is forecasted to be 5.2x, 5.1x, and 5.0x for 2024, 2025, and 2026, respectively [2] - The company's PB ratio is expected to be 1.2x, 1.1x, and 1.0x for 2024, 2025, and 2026, respectively [2] - The dividend yield is projected to be 8.3%, 8.5%, and 8.8% for 2024, 2025, and 2026, respectively [2]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 6.30 [2][4]. Core Views - Despite facing macro challenges, the company has managed to improve profit margins and maintain stable dividends [2]. - The company is expected to continue expanding its market presence, particularly in the overseas markets, while addressing trade challenges through strategic manufacturing locations [2][4]. Financial Overview - For FY2025, the company reported total revenue of HKD 84.7 billion, a decrease of 7.4% year-on-year, with main revenue declining by 7.1% [2]. - The gross profit margin improved to 39.5%, benefiting from a reduction in raw material costs [2]. - The net profit attributable to shareholders was HKD 11.4 billion, with a net profit margin of 51.5% [2]. - The company plans to increase its store count in China by 500-600 stores [2]. Market Performance - The Chinese market saw a decline in revenue by 17.2%, while North American revenue increased by 5.7% [2]. - The company continues to lead in global functional sofa sales, with a significant increase in overseas market revenue [2]. - The average selling price (ASP) in the Chinese market decreased by 10%, impacting overall revenue [2]. Product Performance - Sofa sales in China decreased by 5.8%, while bedding sales grew by 26.6% [2]. - The company is focusing on new product development and enhancing its sales team to drive growth [2]. Future Outlook - The report anticipates that the decline in the Chinese market will narrow in the second half of the fiscal year, supported by government subsidies [2]. - The company is well-positioned to capitalize on long-term growth opportunities in the functional sofa market, which currently has low penetration in China [2].

Investment Rating - The report maintains a "Buy" rating for Atour Hotel (ATAT.US) with a target price of $34.8, representing a potential upside of 37.3% from the current stock price of $25.4 [2][6]. Core Insights - Atour Hotel continues to expand rapidly, focusing on high-end hotel brands, with a total of 1,533 stores as of Q3, including 12 self-operated stores and 1,504 franchise stores [2][6]. - The company reported Q3 revenue of 190 million yuan, a year-on-year decrease of 20.4%, but net profit exceeded Bloomberg consensus expectations, with a GAAP net profit of 38 million yuan, up 45.3% year-on-year [2][6]. - The company has a strong membership growth, with registered members reaching 83 million, a year-on-year increase of 53.7% [2][6]. Financial Overview - For FY24, the company expects revenue growth of 51.9% year-on-year, with projected revenues of 7.09 billion yuan, 8.86 billion yuan in FY25, and 10.57 billion yuan in FY26 [2][6]. - The adjusted net profit is forecasted to be 1.285 billion yuan in FY24, 1.591 billion yuan in FY25, and 1.991 billion yuan in FY26, reflecting significant growth rates [2][6]. - The report highlights a strong retail performance, with GMV reaching 566 million yuan in Q3, a year-on-year increase of 108% [2][6]. Store Expansion and Market Position - The company opened a record number of new stores in Q3, with 140 new openings and a total of 732 stores in the pipeline, indicating a robust expansion strategy [2][6]. - Atour Hotel's RevPAR (Revenue per Available Room) faced pressure due to high base effects from last year's summer travel boom, with a year-on-year decline of 10.5% [2][6]. - The company is enhancing its multi-brand matrix with the introduction of a new high-end service brand, aiming to improve its market share in the mid-range segment [2][6].

Investment Rating - The report maintains a "Buy" rating for Pinduoduo (PDD.US) with a target price of $142.40, representing a potential upside of 37% from the current price of $104.09 [3][5]. Core Insights - The domestic e-commerce sector is focusing on high-quality development, with a 3.2% year-on-year growth in retail sales of consumer goods in the first three quarters of 2024, and a 7.9% increase in online retail sales of physical goods [1]. - Pinduoduo is expected to continue supporting merchants through fee reductions and increased subsidies to maintain price competitiveness, which may impact short-term monetization and profit margins [1]. - The report anticipates that tariffs could negatively affect Temu, with projected global sales of $48 billion in 2024, as external factors may accelerate tariff-related risks [1]. Financial Summary - For Q3, Pinduoduo reported revenues of 99.354 billion RMB, a year-on-year increase of 44%, but below market expectations. Online marketing services revenue was 49.351 billion RMB, up 24% year-on-year, while transaction services revenue reached 50.003 billion RMB, up 72% year-on-year [2]. - Operating profit for the quarter was 29.292 billion RMB, with an operating margin of 24.5%, reflecting a 9 percentage point decline from the previous quarter [2]. - The company’s net profit was 24.981 billion RMB, a 61% increase year-on-year, resulting in a net margin of 25.1% [2]. Revenue and Profit Forecast - The revenue forecast for Pinduoduo has been adjusted to 409.1 billion RMB for 2024, 522.3 billion RMB for 2025, and 627.3 billion RMB for 2026, with corresponding operating profits of 113.3 billion RMB, 134.5 billion RMB, and 168.5 billion RMB respectively [3][4]. - The earnings per ADS are projected to be 83.0 RMB for 2024, 99.8 RMB for 2025, and 124.0 RMB for 2026 [3][4]. Market Position and Competition - The report highlights that the competition among platforms is intensifying, focusing on price competitiveness, user experience, and growth quality [1]. - Pinduoduo is expected to increase its subsidy efforts in Q4 to maintain its competitive edge in pricing [1].

康希诺生物（6185） 更新报告 流脑疫苗带动季度恢复盈利，多管线构建未来增长点 买入 2024 年 11 月 22 日 高小迪 852-25321960 疫情后首次实现单季度盈利：2024Q3 公司营收 2.64 亿元（同比+76.1%， 下同）。前三季度共计营收 5.67 亿元（+222.9%），扣除新冠疫苗预估退 货影响，同比增长 36.9%。前三季度销售费用 1.96 亿元（+1.2%），管理费 用 1.17 亿元（-37.6%），研发费用 2.72 亿元（-41.0%），管理费用和研 发费用支出都有明显降低，公司费用管控效果显著。此外得益于存货及资 产管理的不断优化，公司前三季度资产减值损失同比减少 7.77 亿元，归母 净亏损缩窄至 2.22 亿元。其中 Q3 归母净利润 264 万，在新冠疫情之后首 次实现季度盈利。扣非归母净亏损 672 万。 曼海欣增速喜人，扩龄申报上市在即：公司流脑疫苗产品收入取得高速 增长，前三季度录得 5.16 亿元，同比增长 39.07%。曼海欣在短期内仍将是 国内唯一的 MCV4 产品，有利于其进一步巩固在中国市场的地位。其 4-6 岁 扩龄的申报工作也在积极推进中 ...

Investment Rating - The report maintains a positive outlook on Walmart (WMT.US) with an upgraded fiscal year guidance, indicating resilience in U.S. consumer spending and improved e-commerce efficiency [2]. Core Insights - Walmart's total revenue for Q3 2025 reached $169.6 billion, reflecting a year-over-year growth of 5.5%. The gross margin was 24.2%, an increase of 21 basis points, primarily due to strong inventory management in the U.S. [2] - The operating profit was $6.7 billion, up 8.2% year-over-year, with an operating margin of 4.0%. Earnings per share (EPS) were $0.57, a significant increase of 850% year-over-year, while adjusted EPS was $0.58, up 13.7% [2]. - For the first three quarters of fiscal 2025, operating cash flow was $22.9 billion, a 21% increase year-over-year, and free cash flow was $6.2 billion, up 43% [2]. - Walmart's same-store sales in the U.S. grew by 5.3%, with essential goods maintaining positive growth. International sales increased by 8.0%, with double-digit growth in China [2]. - E-commerce revenue globally grew by 27%, with U.S. e-commerce up 22% and international e-commerce up 43%, driven by in-store pickup, delivery, and third-party seller services [2]. - The report highlights that U.S. retail sales in October increased by 0.4% month-over-month, indicating resilient consumer demand ahead of the holiday season [2]. Financial Projections - For fiscal year 2025, total revenue is expected to grow by 4.8% to 5.1%, with adjusted operating profit projected to increase by 8.5% to 9.25% [2]. - The earnings forecast for fiscal years 2025 to 2027 shows a steady increase in total revenue, operating profit, and EPS, with projected revenues of $680.5 billion in 2025 and $739.7 billion by 2027 [5].

Investment Rating - The report assigns a positive investment rating to Amer Sports (AS), highlighting its strong financial performance and market expansion [2] Core Viewpoints - Amer Sports achieved significant financial results in Q3 2024, with EPS of $0.14, exceeding market expectations by $0.04, and revenue of $1.35 billion, surpassing expectations by $52.888 million [2] - Sales grew by 17% in Q3, driven by the flagship brand Arc'teryx, with an adjusted operating margin of 14.4%, well above the market expectation of 12.3% [2] - The company's performance in the Chinese market was particularly strong, with a 56% growth, and a 47% increase in the Asia-Pacific region (excluding China) [2] - Amer Sports raised its full-year revenue growth forecast to 16%-17%, with the Technical Apparel segment expected to grow by 34%, Outdoor Performance by 8%, and Ball & Racquet by 4% [5] - The company expects low to mid-double-digit annual revenue growth and a 30-70 basis point expansion in adjusted operating margin for 2025 [5] Financial Overview - Technical Apparel segment revenue increased by 34% to $520 million, driven by Arc'teryx, with an adjusted operating margin expanding by 370 basis points to 20% [2] - Outdoor Performance segment revenue grew by 8% to $534 million, primarily due to double-digit growth in Salomon footwear and apparel, though the adjusted operating margin decreased by 40 basis points to 17.5% [2] - Ball & Racquet segment revenue increased by 11% to $300 million, with an adjusted operating margin rising by 600 basis points to 6.9% [2] - Direct-to-consumer (DTC) sales grew by 41% year-over-year, while wholesale revenue increased by 8% to $870 million [2] Market Performance - In the EMEA region, revenue grew by 4% to $430 million, while the US market saw a 7% increase to $490 million [2] - Arc'teryx opened 9 new brand stores globally, bringing the total to 134 stores worldwide [2] - Salomon's footwear and apparel continued to show double-digit growth, with strong performance in Greater China and the Asia-Pacific region [2] Business Outlook - Amer Sports expects full-year adjusted EPS to be between $0.43 and $0.45, with an effective tax rate of approximately 37% and net financial costs estimated at $180-$190 million [5] - The company forecasts operating revenue of $5.122 billion for 2024, with a 17.3% year-over-year increase, and net profit of $153 million, a 173.1% increase from the previous year [7] - For 2025, operating revenue is projected to reach $5.825 billion, with a 13.7% increase, and net profit is expected to grow by 104% to $312 million [7]

快手（1024） 更新报告 | --- | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------|----------------------|------------------------------------------------|-----------------------------------------------------|---------------------------------|---------------|------------------------------------------------------------------------------|--------------------------------------------------------------- ...